These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7634617)
1. Development of skeletal metastases. Kitazawa S; Maeda S Clin Orthop Relat Res; 1995 Mar; (312):45-50. PubMed ID: 7634617 [TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Bouizar Z; Spyratos F; Deytieux S; de Vernejoul MC; Jullienne A Cancer Res; 1993 Nov; 53(21):5076-8. PubMed ID: 8221637 [TBL] [Abstract][Full Text] [Related]
3. Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. Vargas SJ; Gillespie MT; Powell GJ; Southby J; Danks JA; Moseley JM; Martin TJ J Bone Miner Res; 1992 Aug; 7(8):971-9. PubMed ID: 1442211 [TBL] [Abstract][Full Text] [Related]
4. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases. Mihai R; Stevens J; McKinney C; Ibrahim NB Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Chirgwin JM; Guise TA Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy. Bundred NJ; Walls J; Ratcliffe WA Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650 [TBL] [Abstract][Full Text] [Related]
7. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150 [TBL] [Abstract][Full Text] [Related]
8. Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin. Ihnen M; Kilic E; Köhler N; Löning T; Witzel I; Hagel C; Höller S; Kersten JF; Müller V; Jänicke F; Milde-Langosch K J Clin Pathol; 2011 Feb; 64(2):146-52. PubMed ID: 21262777 [TBL] [Abstract][Full Text] [Related]
9. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Powell GJ; Southby J; Danks JA; Stillwell RG; Hayman JA; Henderson MA; Bennett RC; Martin TJ Cancer Res; 1991 Jun; 51(11):3059-61. PubMed ID: 2032246 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer metastasis to bone: it is not all about PTHrP. Bendre M; Gaddy D; Nicholas RW; Suva LJ Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591 [TBL] [Abstract][Full Text] [Related]
11. Biochemical picture of bone metabolism in breast cancer patients with bone metastases. Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Yoneda T; Hiraga T Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401 [TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of bone resorption in breast carcinoma. Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta in osteolytic breast cancer bone metastases. Guise TA; Chirgwin JM Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590 [TBL] [Abstract][Full Text] [Related]
15. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Iguchi H; Tanaka S; Ozawa Y; Kashiwakuma T; Kimura T; Hiraga T; Ozawa H; Kono A Cancer Res; 1996 Sep; 56(17):4040-3. PubMed ID: 8752176 [TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770 [TBL] [Abstract][Full Text] [Related]
17. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer. Iddon J; Bundred NJ; Hoyland J; Downey SE; Baird P; Salter D; McMahon R; Freemont AJ J Pathol; 2000 Jun; 191(2):170-4. PubMed ID: 10861577 [TBL] [Abstract][Full Text] [Related]
18. RANK ligand is a prerequisite for cancer-associated osteolytic lesions. Kitazawa S; Kitazawa R J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883 [TBL] [Abstract][Full Text] [Related]
19. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components. van der Pluijm ; Vloedgraven H; Papapoulos S; Löwick C; Grzesik W; Kerr J; Robey PG Lab Invest; 1997 Dec; 77(6):665-75. PubMed ID: 9426405 [TBL] [Abstract][Full Text] [Related]
20. [PTHrP and breast cancer]. Devys A; Lortholary A; Audran M Bull Cancer; 2001 Nov; 88(11):1075-80. PubMed ID: 11741801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]